Table 1 Clinicopathologic characteristics
From: Chemoresponse after non-curative gastrectomy for M1 gastric cancer
CTx ( n = 76) | NCG + CTx ( n = 25) | P value | ||
|---|---|---|---|---|
Age, years | Mean (SD) | 53.7 (±10.9) | 54.3 (±11.0) | >0.05 |
Sex | Male | 54 (71.1%) | 18 (72.0%) | >0.05 |
Female | 22 (28.9%) | 7 (28.0%) | ||
BMI, kg/m2 | Mean (SD) | 22.0 (±3.2) | 21.8 (±2.2) | >0.05 |
Comorbidity | Yes | 14 (18.4%) | 6 (24.0%) | >0.05 |
Histology | Differentiated | 17 (22.4%) | 7 (28.0%) | >0.05 |
Undifferentiated | 59 (77.6%) | 18 (72.0%) | ||
Tumor location | Upper | 11 (14.5%) | 7 (28.0%) | >0.05 |
Middle | 13 (17.1%) | 1 (4.0%) | ||
Lower | 39 (51.3%) | 13 (52.0%) | ||
Entire | 13 (17.1%) | 4 (16.0%) | ||
cT stage | T1 ~ 3 | 7 (9.2%) | 7 (28.0%) | <0.05 |
T4 | 69 (90.8%) | 18 (72.0%) | ||
Initial M1 site | Peritoneal | 19 (25.0%) | 15 (60.0%) | <0.01 |
Hematogenous | 15 (19.7%) | 5 (20.0%) | ||
Distant LN | 24 (31.6%) | 2 (8.0%) | ||
Mixed | 18 (23.7%) | 3 (12.0%) |